Lose Up to 17% Body Weight on Average with Wegovy
Weight Management Clinic
Thérapie Health Weight Management Clinic offers a personalised, doctor-led programme using Wegovy (semaglutide) to help you achieve safe, sustainable weight loss and long-term health benefits. With continuous medical support, this treatment goes far beyond appearance, it delivers real health gain.
Wegovy, also known as semaglutide, is a licensed, clinically proven prescription medication that supports sustainable, long-term weight loss. It works by mimicking GLP-1, a natural hormone in the gut that helps regulate appetite and reduce food intake, making it easier to manage cravings and maintain a healthy weight.
How Wegovy Works
Wegovy contains semaglutide, a clinically proven medication that mimics the GLP-1 hormone to:
Suppress appetite- Reduce food intake
- Slow stomach emptying
- Support blood sugar regulation
Health Benefits of Wegovy
In addition to weight loss, Wegovy supports:
- Lower blood pressure
- Improved cholesterol levels
- Enhanced cardiovascular and metabolic health
- Better liver and kidney function
- Increased energy and well-being
How to use the Wegovy pen?
You will use a prefilled pen to inject Wegovy under the skin,
once a week, in one of the following areas:
Abdomen
Thigh
Upper Arm
Your doctor will guide you through the process during your visit.
Get Started Today Only €50
Take the first step toward a healthier you.
Complete your online suitability check now and begin your journey to sustainable weight loss and improved health.
Our Clinics
Each location offers comprehensive assessments, prescriptions, and follow-ups to ensure continuity of care.
Our expert team operates across clinics in the Republic of Ireland:
Your Journey to Safe, Doctor-Led Weight Loss: 3 Simple Steps
Why Choose Thérapie Health?
- Safe, sustainable weight loss
- Tailored treatment plans
- Medical expertise you can trust
- Support overall health and vitality
It's More Than Just Weight Loss, It's Health Gain
FAQs
Wegovy contains the active ingredient Semaglutide and Tirzepatide ns the active ingredient Mounjaro both of which are GLP-1 receptor agonists drugs. This means they mimic the actions of GLP1 hormone Mounjaro is a dual agonist, which means it mimics 2 hormones (glucose‐dependent insulinotropic polypeptide (GIP) and GLP-1). Both drugs also have different starting doses and follow a different dose escalation protocol, but they both are effective in weight loss management and have similar side effects.
Wegovy contains the active ingredient Semaglutide and Tirzepatide ns the active ingredient Mounjaro both of which are GLP-1 receptor agonists drugs. This means they mimic the actions of GLP1 hormone Mounjaro is a dual agonist, which means it mimics 2 hormones (glucose‐dependent insulinotropic polypeptide (GIP) and GLP-1). Both drugs also have different starting doses and follow a different dose escalation protocol, but they both are effective in weight loss management and have similar side effects.